Cancer research funds apparently are not linked to whether a type of cancer is deadly. As a matter of fact, often the deadliest cancers get the least research funding from nonprofit research organizations.
Leading health care data and analytics technology and services provider Health Catalyst aims to price 6 million shares for an initial public offering is valued up to more than $158 million.
When a woman is exposed to high levels of air pollution in the week before she gives birth, the baby is more likely to be admitted to a newborn intensive care unit, according to…
It has long been observed that marijuana — or cannabis, weed, grass, or pot, as you prefer — can produce seemingly contradictory psychological effects in the people who smoke (or, these days, vape or…
The American dream is alive and well — at least for most of us — according to a new Gallup poll. Some 70% of those polled said that they consider the American dream to…
"Inaccurate or delayed diagnoses are the most catastrophic and costly of medical errors and will affect most of us in our lifetimes." So says the Society to Improve Diagnosis in Medicine.
This weekend will be a real scorcher in two-thirds of the United States. Some cities have already set up cooling stations to prevent serious consequences, including heat stroke and heat exhaustion.
A major heat wave will hit two-thirds of the United States this weekend and may come with potentially very serious consequences, including heat stroke and heat exhaustion.
Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to blame. Some rivals may have been winning at the company's expense.
Inovio Pharma shares dipped on Wednesday after the company said that it was taking measures to cut costs and its overall burn rate. When a company says it’s cutting costs one thing it can…
Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
24/7 Wall St. has picked a few biotech standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.